|
1
|
The use of PET in Alzheimer disease.
|
Nat Rev Neurol
|
2010
|
2.13
|
|
2
|
Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients.
|
J Alzheimers Dis
|
2011
|
0.86
|
|
3
|
Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2012
|
0.82
|
|
4
|
Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.
|
Neurocase
|
2014
|
0.75
|